These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Acute methotrexate toxicity in psoriasis]. Arévalo-López A Gac Med Mex; 1999; 135(5):513-6. PubMed ID: 10596492 [TBL] [Abstract][Full Text] [Related]
24. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage]. Haber R; Baroudjian B; Battistella M; Bagot M; Petit A Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574 [TBL] [Abstract][Full Text] [Related]
26. Cutaneous ulceration induced by leflunomide in a psoriatic patient. Di Nuzzo S; Zanni M; De Panfilis G Int J Dermatol; 2009 Jun; 48(6):666-8. PubMed ID: 19538387 [No Abstract] [Full Text] [Related]
27. More than skin deep. Riquelme-Mc Loughlin C; Giavedoni P; Mascaró JM Am J Emerg Med; 2018 Sep; 36(9):1719.e3-1719.e4. PubMed ID: 29861373 [TBL] [Abstract][Full Text] [Related]
28. A case of methotrexate intoxication in a patient with psoriasis who drank beetroot juice during methotrexate treatment. Gönül M; Keseroglu H; Hacınecipoğlu F Clin Exp Dermatol; 2016 Dec; 41(8):893-895. PubMed ID: 27859605 [TBL] [Abstract][Full Text] [Related]
29. [4pp Mucocutaneous manifestations of methotrexate toxicity]. Ferrari B; Kogan N; Veira RC; Luna PC; Larralde M; Cuesta MG; Díaz P; Rossi MV; Aloise I Medicina (B Aires); 2018; 78(1):50-53. PubMed ID: 29360079 [TBL] [Abstract][Full Text] [Related]
30. Methotrexate toxicity induced by ciprofloxacin leading to psoriatic plaque ulceration: a case report. Kamangar F; Berger TG; Fazel N; Koo JY Cutis; 2013 Sep; 92(3):148-50. PubMed ID: 24153144 [TBL] [Abstract][Full Text] [Related]
32. Severe Pancytopenia Following Single Dose Methotrexate In Psoriasis: A Rare And Potentially Lethal Manifestation. Singh A; Choudhary R; Chhabra N; Ganguly S; Rathore V Curr Drug Saf; 2021; 16(1):110-113. PubMed ID: 33106147 [TBL] [Abstract][Full Text] [Related]
33. [Extensive erosive hemorrhagic lesions in psoriasis plaques caused by methotrexate poisoning]. Rytter M; Haustein UF Dermatol Monatsschr; 1989; 175(1):55-8. PubMed ID: 2522069 [No Abstract] [Full Text] [Related]
34. Methotrexate-induced cutaneous ulcers in a nonpsoriatic patient: case report and review of the literature. Kurian A; Haber R J Cutan Med Surg; 2011; 15(5):275-9. PubMed ID: 21962187 [TBL] [Abstract][Full Text] [Related]
35. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy]. Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945 [No Abstract] [Full Text] [Related]
36. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study. Bjerring P; Beck HI; Zachariae H; Søgaard H Acta Derm Venereol; 1986; 66(6):515-9. PubMed ID: 2433872 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin. Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005 [TBL] [Abstract][Full Text] [Related]
38. Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial. Fallah Arani S; Neumann H; Hop WC; Thio HB Br J Dermatol; 2011 Apr; 164(4):855-61. PubMed ID: 21175564 [TBL] [Abstract][Full Text] [Related]